Latest news
Intellia Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 06:04:09 GMTIntellia Therapeutics 2Q 2026: Revenue $7.7M, Net loss $106.6M, EPS $(0.80) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTIntellia Prepares for Anticipated 2027 Commercial Launch of First In Vivo Gene Editor - Precision Medicine OnlinePrecision Medicine Online · Thu, 06 Aug 2026 19:23:40 GMT